Yerevan, 12.February.2026,
00
:
00
ՄԵՆՅՈՒ
Futsal tournament Galaxy Champions League 2024 kicks off Unibank is now a regular partner of “Pan-Armenian intellectual movement” IDBank issued another tranche of dollar bonds Green Iphone on the best credit terms at green operator's stores UCOM Provided technical assistance to Shengavit administrative district AMD 9,808,684 to the "City of Smile" Charitable Foundation. The next beneficiary of "The Power of One Dram" is known Unibank offers a “Special” business loan with an interest rate of 8.5% per annum IDBank implements the next issue of nominal coupon bonds Flyone Armenia will start operating regular direct flights Yerevan-Moscow-Yerevan New movie channels in Ucom and good news for unity tariff subscribers


Female Viagra: still a tough pill to swallow? We asked experts

Lifestyle

At last, sisters! “female Viagra” is upon us! Thanks to flibanserin (also known by its brand name, Addyi) and its revolutionary female-libido-enhancing properties, we are free. Free to pop lady-boners at the time and place of our choosing! Free to discuss the precise nature and frequency and satisfactoriness of our sexual encounters with doctors! Free to … well, reportedly, free to have about one more sexual encounter per month, assuming we are among the 9% to 15% of womenfor whom Addyi actually works.

We are also free to take this pill every day – because, unlike Viagra, Addyi is a central nervous system drug, much like an anti-depressant. We are free to experience side effects, including dangerously low blood pressure and fainting, especially when combined with alcohol. And we are free to live with a female ailment – “hypoactive sexual desire disorder” according to Dr Anita Clayton of the University of Virginia, who conducted some flibanserin trials — that some expertsdoubt even exists.

“The real problem that I have with this is that this is framed in terms of dysfunction,” says Rachel Hills, author of The Sex Myth. “For a drug to be passed, it needs to be treating an illness. So for a drug to be passed to treat women’s lack of desire, that has to be a [medical] problem.”

Hills’ concern is grounded in history. Western medicine, for all its wonders, has a distinct habit of pathologizing women’s sex lives. Aside from the fact that same-sex attraction was once considered a mental illness, and that “gender dysphoria” (or being transgender) is still listed in the DSM, you could look to Freud’s insistence that clitoral orgasms were a form of neurosis, or to “hysteria”, an illness that supposedly accounted for both masturbation and frigidity. At the height of the “hysteria” fad, one doctor estimated that 75% of women were affected. In 2015, of course, 0% of women have hysteria, because the disease doesn’t exist.

But we do have a drug that women can take if they don’t want sex often enough – although “enough” is, of course, a highly subjective term, and in a culture where women are pressured to be sexually accommodating to male partners at all times, a difficult one to measure.

Hills points out that, in reporting her book, she found that most women had an idea of how much sex should be “enough” for them, whether they actually wanted it or not.

“The women I interviewed, more so than the men even, internalized the idea that sex needed to be done at a certain frequency,” Hills says. “Which was universally two to three times a week, because that’s what they’d read in women’s magazines.”

Feeling bad about yourself because you don’t want sex as often as a magazine tells you to is less a problem with you than it is with the magazine. There’s also the fact that loss of interest in sex, to the extent that it is felt to be a problem by the woman in question, can be caused by any number of situational factors.

“The illusion that low sexual desire is a physical disease in need of a cure [is] obscuring other reasons for low desire and other, less dangerous ways of dealing with these issues,” says Dr Laurie Mintz, psychology professor at the University of Florida and author of A Tired Woman’s Guide to Passionate Sex.

In her own work, Mintz has found that “most women have such a decrease as they age and as their relationship ages”. She also lists a plethora of other reasons that sex might move down on a woman’s priority list. Number one, she says, is simple stress and exhaustion. If a woman tells you she’s tired tonight, she probably means it.

“There is ample evidence that stress affects women’s sex drives more than men’s,” Mintz says. “Other reasons include relationship issues (anger, too much closeness, not enough closeness), unsatisfactory sex and/or painful intercourse.”

Dr Clayton told me that a diagnosis of hypoactive sexual desire disorder, or a flibanserin prescription, was not intended to supplant psychotherapy. She says that HSDD (which she argues affects 10% of women) describes a loss of sexual desire that is distressing to the woman in question, and is not caused by situational factors.

“Our desire might be impacted because we don’t have any privacy, it might be impacted because we’re angry at our partner,” Dr Clayton says. “Normal desire rebounds. If we go on vacation and we have opportunities and release of stress, sexual desire bounces back. But for about 10% of women that’s not the case. They used to have what they would consider normal sexual desire … they experience a decline, or in some cases even a complete absence.”

To prove that flibanserin should be treated as a real medical problem, Clayton tells me, a questionnaire was designed – the Decreased Sexual Desire Screener – for women to take with their doctors. It’s five questions long, and asks, simply, (a) whether you used to have a “satisfying” level of sexual interest, (b) whether that’s changed, and (c) whether you see that change as a problem, and would like to fix it. Women are also given an opportunity to check off potential contributing factors, including “stress or fatigue,” relationship problems, or other medical conditions. It’s when there are no potential contributing factors, Clayton says, that HSDD might be diagnosed and treated.

Still. The price tag on flibanserin – Sprout, the makers of Addyi, were just purchased for $1bn– seems to show that there’s substantial interest in commodifying women’s lack of desire, or simply their desire to desire more than they do.

For women genuinely distressed by their lack of sexual desire – and these women do exist, and their pain is not inconsiderable – flibanserin might represent a ray of hope. But for critics, it represents both a new “hysteria” and a new “restless leg syndrome” – a disease created because there is a profit in curing it, and another way for experts to tell women their sexuality isn’t OK.

“When it comes to sex, there is no ‘normal,’” says Therese Schecter, director of How To Lose Your Virginity (for which, full disclosure, I was interviewed). “There’s no right way to have sex for the first time, no timetable for sexual experiences, no perfect amount of sex to have, and no requirement to even have sex at all. Saying ‘normal’ exists, and ‘normal’ is a moving target depending on who you ask, means there’s something wrong with anyone who doesn’t conform. Meaning, all of us.”

Unibank Became an A-Level Member of the Armenia British Business Chamber Winter adventures continue at Myler: Idram&IDBankWith the Support of AraratBank, KardaLove 5th Anniversary Festival Returns in a New FormatThe Power of One Dram — to Mathemik NGOIDBank’s Nor Nork branch has reopenedOn the impossibility of making payments via Idram for telecommunication operators’ services and the current situationWhen CSR Becomes a Driving Force for Business Development: Lala Bakhshetsyan Five-Year Partnership Between AraratBank and 4090 Charity Foundation Comes to Successful Close Idram and Weixin Pay (WeChat Pay) Launch Strategic Partnership in ArmeniaThe Winners of the Third Round of the Junius Competition Have Been AnnouncedWhat to gift men on January 28: Idram&IDBankIdram Conducted a Financial Literacy Class for Roboton ParticipantsRegarding Payments for Viva Armenia Services via IdramVahe Hakobyan Is a Political Prisoner: Past.amUp to 2% Cashback with IDBank Mastercard and ARCA CardUp to 2% cashback, free Mastercard and free ArCa card when you join IDSalaryAraratBank Sums Up “You Choose the Destination” Campaign Implemented in Partnership with MastercardBook by March 31 and get 15% off your FINTECH360 ticket Ucom Launches Fixed Network Services in Zovuni The FINTECH360 conference will be held in Yerevan from April 27 to 29 AraratBank Partners as General Sponsor of 4090 Charity Foundation's Five-Year Milestone EventAraratBank Takes the Lead in Brand PR Performance Unforgettable Moments and a Profitable Offer at Myler. Idram&IDBank Idram Summarizes 2025The Power of One Dram Donates 5,788,105 AMD to the City of Smile Charity Foundation Converse Bank Successfully Completes Globbing Bond Placement Why the Pressure on Vahe Hakobyan Continues Ucom Introduces Hecttor AI to Improve Call Center Communications The Armenian Apostolic Church: Refutation of a False Premise Vahe Hakobyan Is Being Politically PersecutedIdram employees are the Secret Santa Claus for the students of the Orran Day Care CenterAraratBank Donates AMD 8 million to the Reconstruction of the Spandaryan CanalUnibank Launches Gift Cards New Education Platforms through Cooperation between AraratBank and Aren Mehrabyan FoundationTech Innovator and Winemaker Adam Kablanian Joins the Board of Trustees of the “Music for Future” FoundationUcom Reopens Sales and Service Center on Tigran Mets Avenue AraratBank Receives Visa Trusted Partnership Award 2025 Secret Santa at idplus: Anonymous Gift CardsWe condemn the unlawful actions by Armenia’s Gov. against the Armenian Apostolic Church. Jan Figel Free Style issues Armenia’s first corporate bonds in the fashion retail sector, placed by Cube InvestUnibank Completed the Placement of Its Third Issuance of Perpetual BondsScholarship for 100 Artsakh Students as Part of IDBank’s “Side by Side” Program The results of the second Junius financial literacy competition have been summarized From idea to implementation: Ameriabank Presents the Programs Implemented under My Ameria, My Armenia CSR Campaign Ucom and SunChild Launch the “Smart Birdwatching” Educational Program AraratBank Supports Digitization of "Karin" Scientific Center ArchiveWelcome to the ID booth: Big Christmas MarketWidest 5G Coverage, the Launch of the Uplay Platform, and the Integration of Cerillion: Ucom Summarizes 2025 Ucom and Armflix Present “13 Seconds” at KinoPark How to Choose a Career Path and What Skills are Considered Crucial: AraratBank on the GoTeach Platform